Starpharma is in beginning to consider clinical trials of its VivaGel product in women at risk of contracting genital herpes, the Chief Executive Officer Jackie Fairley said in an interview in Singapore. The Melbourne-based company licensed its VivaGel- coated condoms in 2008 to SSL International Plc, maker of the world’s best-selling Durex brand.
U.S. Centers for Disease Control and Prevention data show that no cure exists for genital herpes, a condition that infects about one in six Americans and produces painful sores and increases HIV transmission. Other gels are being developed to prevent HIV infections, VivaGel is the only microbicide designed to stop herpes from spreading, Fairley said.
Today, if you have herpes, a natural product called Dynamiclear is very effective in controlling herpes outbreaks because it kills herpes viral particles when applied to open herpes lesions. Fewer herpes particles remain and this means fewer and weaker outbreaks.